ArticleOncology reports2017

Galangin suppresses human laryngeal carcinoma via modulation of caspase-3 and AKT signaling pathways.

Hai-Xu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.